Business Development Executive

KONSTANTINE HARALAMPOPOULOS

+1-312-***-**** WhatsApp *********@*****.*** linkedin.com/in/haralampopoulos/ Seasoned Global Business Development Manager with comprehensive international market understanding Equipped with skills in strategic planning, relationship building, and negotiation for driving business growth globally Proven track record in identifying new opportunities and forging strong relationships with partners to maximize revenue Known for innovative strategies that yield significant increases in market share and overall profitability Professional Experience

FRESENIUS KABI (SEP 2024 – MAY 2025) Remote

Senior Global Business Development Manager, (Contractual Role for Start-Up CDMO) Individual Contributor focused primarily on Monoclonal Antibodies (mAbs) and Antibody Drug Conjugates (ADC) Manufacturing Opportunities and Creating a CDMO Business Development Playbook and Roll-Out Initiative Won two deals worth a combined $94,000,000 Valuation:

• Secured Development and Fill/Finish Manufacturing Project for New Glucagon Application: $7,700,000 Commercial Revenue: $34,000,000

• Secured Development Project for New IV Bag Transplant Application: $3,800,000. Commercial Revenue: $60,000,000

• In 8 months: Signed-Off on 11 CDAs. Completed 5 ADC Prospect Tour Visits CARETAKER (JUL 2023 – AUG 2024)

On Behalf of Elderly Parents

CENTER FOR BREAKTHROUGH MEDICINES (JUN 2022 – JUN 2023) Remote Director Global Business Development (Contractual Role for Start-Up CDMO) Cell & Gene Therapy Testing and Manufacturing

Undertook Business Development Playbook Roll-Out Including:

• Hired and Trained Two North American Sales Managers

• Implemented CRM (Salesforce), Prospecting (Global Data) and Quotation (Panadoc) Software

• Trade Show and Conference Exhibitor. Hosted Webinar Presentations, Tour Visits, Lunch and Learns.

• Secured $3,200,000 in Analytical Testing Opportunities for EMEA Targets DAICEL (JAN 2020 – MAR 2022) Strasbourg, France

Director Global Business Development (Contractual Role for Start-Up CRO) Medical Device and Small / Large Molecule GMP Analytical Testing for New Business Unit

• Secured $2,400,000 for Medtech, Pharma and BioPharma Clients focused on Injectables, Inhalation, Infusion, Transdermal, Solid Oral Dose, Topicals and Ocular Drug Delivery for Branded, Generics and Biosimilars

• Expanded offerings to include: APIs, Reference and Labeled Standards. Cross-Sold Daicel Chiral Columns to Pharmaceutical and New Distribution Channels to EMEA, LATAM and APAC

• Collaborated with Marketing Agency to Develop Branded Digital Content and Analytical Tracking Reports

• Created White Papers for LinkedIn Broadcast and Life Science Newsletter Resulting in 280% Subscription Increase

• Hosted Drug Development Solution Webinars. Negotiated Client Proposals and Contracts SGS (JAN 2017 – DEC 2019) Global

Director Business Development. Small / Large Molecule and Medical Device GMP Analytical Testing CRO

• 2019: Closed Largest Single Deal for SGS Life Sciences NA ($2,300,000)

• 2019: Exceeded $9,000,000 Revenue Target. Global Rank: 1 /17

• Clinical Trials and Commercial Medicine Launches / New Indications for Immunology, Neurology, Rare Disease, Ophthalmology, Psychiatry, Dermatology, Oncology, Cardiology, Wound Care, Pulmonology

• BioPharmaceutical Services: Microbiology, Bioanalytical, PK, Immunogenicity, Stability, Extractable / Leachable, CMC, Formulation, Method Development / Validation / Transfer

• MedTech Service Applications: POC and OTC Rapid Testing, Infusion Pumps and Orthopaedic Implants

• Call Points: Procurement, Engineering, R&D, QA, RA, QC as well as Director and Vice President Level HENKEL (JAN 2010 – DEC 2016) Dusseldorf, Germany

Global Key Account Manager (GKAM)

Launched Loctite GTM Adhesive Technology for Becton-Dickinson (BD) and Baxter Key Accounts

• 2016: €12,000,000 Sales Pipeline (+26% Target) Which Included Sterile Injectable Finished Drug Product and IV bag

• 2014: Secured BD Sustainability Vendor of the Year Award for Syringe Bonding Applications (Vaccines / Prefilled Syringes)

• Co-Managed Six Regional Managers Across Five Continents. Call Points: R&D, Procurement, Engineering, / C-Level JOHNSON & JOHNSON (JAN 2004 – DEC 2009) Chicago, IL USA District Manager

Exceeded Sales Expectations in Key Client Facing Role by Turning Around Underperforming Territory / District

• Represented Levaquin (anti-infective) and Launched PillCam In Vitro Diagnostic Medical Device (Gastroenterology) and Ultram ER analgesic Medication (Neurology and Pain Medicine).

• Managed 10 direct reports. Conducted Performance Reviews. Trained New hires. Completed Leadership Programme.

• Hospital Privileges, Formulary, Buy and Bill Experience. Hosted

• MAR 2009 Ranked: District: 1 / 9 Region: 2 / 94 Nation: 27 / 556

• Largest Leaper Award Recipient (2005) and Presidents Club (2008-2009)

• Dermatology, Neurology, Orthopedics, Infectious Disease, Pulmonology, Urology, Nephrology, Women’s Health, ER, Wound KONFIDANT (JAN 1996 – DEC 2003) Global

Lead Consultant

Created Consultancy to Serve First Mover Medical Products and Services for Early Adopter Clients and KOLs Noteworthy Key Takeaway Project Achievements Include: Pioneer for Disruptive Point-of-Care Technology

Established Advanced Pain Treatment Centers as Global Best-in-Class Pain Medicine Treatment Practice

• Created $15,000,000 Valuation of Minimally Invasive Start-up Launch (+15% CAGR with 8 Years)

• Established Physician, Ambulatory and Anesthesia Revenue Streams as an End-to-End Pain Medicine Practice

• Coordinated Real World Evidence Study Resulting in 320% Increase Commercial Insurance Payer Reimbursements

• Cross Trained 15 Clinical and Administrative Employees Resulting in 12% Cost Savings

• Opened and coordinated 3 Clinical Sites Including EU Market Expansion

• CME Speaker at Pain Medicine Conferences: Pain Billing, Strategic Growth, Healthcare Delivery and Access

• Referral Sources: Orthopedic Surgeons, Psychiatry, Neurology, Rheumatology for Spinal and Migraine Conditions Launched Diabetes Risk Assessment (DRA) – Rapid IVD for the B2B and B2C marketplace

• DRA Selected as First-Line Go To Market Screen for Type 2 Diabetes by Harvard School of Dental Medicine

• Secured Private label OTC Distribution Deal ($5,000,000) to Ophthalmologists, Dentists and Primary Care Physicians Upstream Marketing and Sales Support to GE Healthcare Capital Equipment

• Provided Next-Gen Enhancement Recommendations for Fluoroscopy Diagnostic Imaging Re-Launch (C-Arm)

• Worked in the Operating Room Guiding C-Arm and Assisting Surgeon During Procedures

• Represented GE Healthcare at Radiology Trade Shows and Conferences Over 2 Year Period

• Direct efforts resulted in a +9% YTY Market Share Penetration for Purchase Orders within 2 Years Education

UNIVERSITY OF CHICAGO, MBA, Booth Graduate School of Business

• Summer Rotational Internship: Citibank Europe (Finance, Investment and Retail Banking) UNIVERSITY OF ILLINOIS, Bachelor’s of Science, Biological Sciences

• Research Assistant, Genetics Department

• English Writing and Composition Tutor

• Athletics Scholarship (Track and Field)

Additional Information

• Dual Citizen USA / EU

• Adjunct Professor, University of St Francis (Business Strategy / Marketing Courses)

• Distinguished Allscripts (SaaS) Continuing Medical Education (CME) Panelist & Key Note Speaker: EMR Coding, Billing, Payer Reimbursement Negotiation

• Native Speaker: Greek / English. Working Knowledge: Spanish

Contact this candidate